C12Y 402/02019
Chondroitin b lyase
Official title: Chondroitin B lyase (4.2.2.19)
C12Y402/02019 (Chondroitin b lyase) appears on 15 US grants and 18 published applications in this corpus.
Search patents in C12Y- Granted patents
- 15
- Published applications
- 18
- Assignees
- 6
- Inventors
- 14
- Latest grant
- 1 May 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 1 | 3 |
| 2010 | 1 | 0 |
| 2011 | 2 | 2 |
| 2012 | 1 | 1 |
| 2013 | 2 | 3 |
| 2014 | 3 | 0 |
| 2015 | 1 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 1 | 0 |
By publication year.
Recent patents
- Compositions and methods for promoting neuronal outgrowth1 May 2018US 9,956,273 B2Acorda Therapeutics, Inc.
- Pharmacological vitreolysis26 Sep 2017US 9,770,494 B2ThromboGenics NV
- Compositions and methods for promoting neuronal outgrowth18 Oct 2016US 9,468,671 B2Acorda Therapeutics, Inc.
- Pharmacological vitreolysis17 Nov 2015US 9,186,394 B2ThromboGenics NV
- Pharmacological vitreolysis16 Sep 2014US 8,834,869 B2ThromboGenics NV
- Compositions and methods for promoting neuronal outgrowth29 Sep 2016US 2016/0279210 A1Acorda Therapeutics, Inc.
- Pharmacological vitreolysis5 Mar 2015US 2015/0064161 A1ThromboGenics NV
- Compositions and methods for promoting neuronal outgrowth22 Jan 2015US 2015/0023942 A1Acorda Therapeutics, Inc.
- Pharmacological vitreolysis14 Nov 2013US 2013/0302304 A1ThromboGenics NV
- Pharmacological vitreolysis8 Aug 2013US 2013/0202613 A1ThromboGenics NV
Most cited
By later US patents
- Pharmacological vitreolysis11US 7,547,435 B2ThromboGenics NV · 2009
- Pharmacological vitreolysis9US 7,803,368 B2ThromboGenics NV · 2010
- Pharmacological vitreolysis9US 7,867,489 B2ThromboGenics NV · 2011
- Pharmacological vitreolysis9US 7,914,783 B2ThromboGenics NV · 2011
- Pharmacological vitreolysis8US 8,383,105 B2ThromboGenics NV · 2013